Ticker name:MDGLMADRIGAL PHARMACEUTICALS, INC.
Country: US-Sector: Healthcare, Industry: Biotechnology
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
- CEO: William J. Sibold
- IPO: Feb 06, 2007
- Website:...igalpharma.com (open a new tab)
Market Cap 12B
Last close 535.69$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 122B | 480.5$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 70B | 672.15$ | |
| 3 | RVMD | Revolution Medicines, Inc. | 38B | 180.39$ | |
| 4 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 36B | 272.67$ | |
| 5 | ROIV | Roivant Sciences Ltd. | 24B | 34.05$ | |
| 6 | MRNA | Moderna, Inc. | 24B | 59.49$ | |
| 7 | INSM | INSMED Inc | 23B | 107.02$ | |
| 8 | INCY | INCYTE CORP | 23B | 115.65$ | |
| 9 | UTHR | UNITED THERAPEUTICS Corp | 22B | 529.34$ | |
| 10 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 173$ | |
| 11 | BBIO | BridgeBio Pharma, Inc. | 16B | 80.76$ | |
| 12 | ASND | Ascendis Pharma A/S | 16B | 251.76$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 243.47$ | |
| 14 | EXEL | EXELIXIS, INC. | 14B | 55.53$ | |
| 15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 535.69$ | |
| 16 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 59.11$ | |
| 17 | AXSM | Axsome Therapeutics, Inc. | 11B | 221.64$ | |
| 18 | TECH | BIO-TECHNE Corp | 11B | 71.64$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 10B | 13.5$ | |
| 20 | APGE | Apogee Therapeutics, Inc. | 10B | 134.15$ |